top of page

Tieteelliset tutkimukset mRNA:sta

Myocarditis after vaccination against covid-19

Cardiac

Myocarditis and or pericarditis after mRNA vaccination, head to head comparison of Moderna versus Pfizer

Cardiac

Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines

Cardiac

Myocarditis and Pericarditis After COVID-19 mRNA Vaccination, Practical Considerations for Care Providers

Cardiac

Myocarditis and pericarditis after vaccination for COVID-19

Cardiac

Myocarditis and Pericarditis following COVID-19 Vaccination, Inequalities in Age and Vaccine Types

Cardiac

Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination, What Do We Know So Far

Cardiac

Myocarditis and pericarditis following mRNA vaccination in autoimmune inflammatory rheumatic disease patients, A single-center experience

Cardiac

Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccine

Cardiac

Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination, cases from a regional pharmacovigilance centre

Cardiac

Myocarditis Associated With COVID-19 Booster Vaccination

Cardiac

Myocarditis Associated With COVID-19 Vaccination Circulation, Cardiovascular Imaging

Cardiac

Myocarditis associated with COVID‑19 vaccination in three male teenagers

Cardiac

Myocarditis Associated with mRNA COVID-19 Vaccination Radiology

Cardiac

Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021

Cardiac

Myocarditis Following a COVID-19 Messenger RNA Vaccination, A Japanese Case Series

Cardiac

Myocarditis Following Coronavirus Disease 2019 mRNA Vaccine, A Case Series and Incidence Rate Determinati

Cardiac

Myocarditis Following Coronavirus Disease 2019 mRNA Vaccine, A Case Series and Incidence Rate Determination

Cardiac

Myocarditis following COVID-19 mRNA (mRNA-1273) vaccination

Cardiac

Myocarditis following COVID-19 mRNA vaccination 1

Cardiac

bottom of page